Literature DB >> 17378821

The association between customised small for gestational age infants and pre-eclampsia or gestational hypertension varies with gestation at delivery.

K M Groom1, R A North, K K Poppe, L Sadler, L M E McCowan.   

Abstract

OBJECTIVES: (1) To describe the association between small for gestational age (SGA) infants and pre-eclampsia (PE) and gestational hypertension (GH) and (2) to determine how this association changes with gestational age at delivery using customised centiles to classify infants as SGA.
DESIGN: A retrospective observational study.
SETTING: National Women's Hospital, a Tertiary Referral Centre in Auckland, New Zealand. POPULATION: A total of 17 855 nulliparous women delivering between 1992 and 1999.
METHODS: A comparison of the number of women with a customised SGA infant, PE and GH according to gestational age at delivery. MAIN OUTCOME MEASURES: The incidence of SGA infants (defined as birthweight <10th customised centile), PE and GH at <34, 34-36(+6) and > or =37 weeks.
RESULTS: A total of 1847 (10.3%) infants were SGA, 520 (2.9%) women had PE and 1361 (7.6%) had GH. SGA, PE and GH all occurred more commonly with increasing gestation at delivery with 85%, 62% and 90% of cases delivered at term. In women delivering SGA infants, coexisting PE was more likely to occur among those delivered preterm than at term (38.6% at <34 weeks [relative risk, RR 10.2 95%CI 7.3-14.4], 22.4% at 34-36(+6) weeks [RR 6.0 95%CI 4.1-8.6] and 3.8% at > or =37 weeks [OR 1.0]). Women with preterm PE were more likely to have a SGA infant than women with term PE (57.1% at <34 weeks [RR 3.1 95%CI 2.3-4.2], 31.7% at 34-36(+6) weeks [RR 1.7 95%CI 1.2-2.5]) and 18.3% at > or =37 weeks [OR 1.0]). There was a similar association between GH and SGA infants as gestation advanced (57.6% at <34 weeks [RR 4.8 95%CI 3.4-6.6], 30.5% at 34-36(+6) weeks [RR 2.5 95%CI 1.8-3.5] and 12.1% > or =37 weeks [OR 1.0]).
CONCLUSIONS: SGA infants and PE are more likely to coexist in preterm births compared with term births. This is likely to reflect the degree of placental involvement in each disease process.

Entities:  

Mesh:

Year:  2007        PMID: 17378821     DOI: 10.1111/j.1471-0528.2007.01277.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  10 in total

1.  Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.

Authors:  JoonHo Lee; Roberto Romero; Zhong Dong; Deug-Chan Lee; Yi Dong; Pooja Mittal; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

2.  Further evidence for the role of pregnancy-induced hypertension and other early life influences in the development of ADHD: results from the IDEFICS study.

Authors:  Hermann Pohlabeln; Stefan Rach; Stefaan De Henauw; Gabriele Eiben; Wencke Gwozdz; Charalampos Hadjigeorgiou; Dénes Molnár; Luis A Moreno; Paola Russo; Toomas Veidebaum; Iris Pigeot
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-03-03       Impact factor: 4.785

3.  Estimated reductions in provider-initiated preterm births and hospital length of stay under a universal acetylsalicylic acid prophylaxis strategy: a retrospective cohort study.

Authors:  Joel G Ray; Emily Bartsch; Alison L Park; Prakesh S Shah; Susie Dzakpasu
Journal:  CMAJ Open       Date:  2017-06-23

4.  Gestational Weight Gain: Results from the Delta Healthy Sprouts Comparative Impact Trial.

Authors:  Jessica L Thomson; Lisa M Tussing-Humphreys; Melissa H Goodman; Sarah E Olender
Journal:  J Pregnancy       Date:  2016-08-09

5.  Prediction of Small for Gestational Age Infants in Healthy Nulliparous Women Using Clinical and Ultrasound Risk Factors Combined with Early Pregnancy Biomarkers.

Authors:  Lesley M E McCowan; John M D Thompson; Rennae S Taylor; Philip N Baker; Robyn A North; Lucilla Poston; Claire T Roberts; Nigel A B Simpson; James J Walker; Jenny Myers; Louise C Kenny
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

6.  Maternal blood lead levels and the risk of pregnancy-induced hypertension: the EDEN cohort study.

Authors:  Chadi Yazbeck; Olivier Thiebaugeorges; Thierry Moreau; Valérie Goua; Ginette Debotte; Josiane Sahuquillo; Anne Forhan; Bernard Foliguet; Guillaume Magnin; Rémy Slama; Marie-Aline Charles; Guy Huel
Journal:  Environ Health Perspect       Date:  2009-06-26       Impact factor: 9.031

7.  Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort.

Authors:  Liv Cecilie V Thomsen; Phillip E Melton; Kjersti Tollaksen; Ingvill Lyslo; Linda T Roten; Maria L Odland; Kristin M Strand; Ottar Nygård; Chen Sun; Ann-Charlotte Iversen; Rigmor Austgulen; Eric K Moses; Line Bjørge
Journal:  J Hypertens       Date:  2015-11       Impact factor: 4.844

8.  Clinical prediction in early pregnancy of infants small for gestational age by customised birthweight centiles: findings from a healthy nulliparous cohort.

Authors:  Lesley M E McCowan; John M D Thompson; Rennae S Taylor; Robyn A North; Lucilla Poston; Philip N Baker; Jenny Myers; Claire T Roberts; Gustaaf A Dekker; Nigel A B Simpson; James J Walker; Louise C Kenny
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  Association between reduced stillbirth rates in England and regional uptake of accreditation training in customised fetal growth assessment.

Authors:  Jason Gardosi; Sally Giddings; Sally Clifford; Lynne Wood; André Francis
Journal:  BMJ Open       Date:  2013-12-17       Impact factor: 2.692

10.  The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity.

Authors:  Joao Guilherme B Alves; Carla Adriane Fonseca Leal de Araújo; Isabelle E A Pontes; Angélica C Guimarães; Joel G Ray
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-08       Impact factor: 3.007

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.